Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Forecast Score | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TGTX | TG THERAPEUTICS INC | $2.61B | $16.92 | $31.20 | 84.40% | Strong Buy | 5 | 28.50% | 61.87% | N/A | N/A | ||||
| SRPT | SAREPTA THERAPEUTICS INC | $12.51B | $132.30 | $161.33 | 21.94% | Strong Buy | 12 | 28.07% | 153.38% | N/A | N/A | ||||
| INCY | INCYTE CORP | $12.01B | $53.50 | $74.92 | 40.04% | Buy | 13 | 10.20% | 41.93% | N/A | N/A | ||||
| HALO | HALOZYME THERAPEUTICS INC | $5.58B | $43.84 | $54.00 | 23.18% | Buy | 6 | 14.42% | 41.76% | N/A | N/A | ||||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $1.78B | $31.28 | $39.80 | 27.24% | Hold | 5 | 15.57% | 38.33% | N/A | N/A | ||||
| CORT | CORCEPT THERAPEUTICS INC | $2.77B | $26.60 | $40.67 | 52.88% | Strong Buy | 3 | 13.45% | 24.89% | N/A | N/A | ||||
| CPRX | CATALYST PHARMACEUTICALS INC | $1.85B | $15.65 | $27.40 | 75.08% | Strong Buy | 5 | 15.09% | 20.89% | N/A | N/A | ||||
| RPRX | ROYALTY PHARMA PLC | $16.71B | $27.97 | $43.33 | 54.93% | Strong Buy | 3 | 14.15% | 60.66% | N/A | N/A | ||||
| GMAB | GENMAB A | $19.05B | $28.81 | $45.00 | 56.20% | Buy | 4 | 18.93% | 37.91% | N/A | N/A | ||||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $15.52B | $81.72 | $100.90 | 23.47% | Buy | 10 | 11.02% | 81.99% | N/A | N/A | ||||
| MNKD | MANNKIND CORP | $1.17B | $4.31 | $7.00 | 62.41% | Strong Buy | 2 | 15.15% | 132.08% | N/A | N/A | ||||
| TECH | BIO-TECHNE CORP | $12.55B | $79.63 | $80.71 | 1.36% | Strong Buy | 7 | 6.18% | 33.92% | N/A | N/A | ||||
| EXEL | EXELIXIS INC | $6.34B | $21.76 | $27.25 | 25.23% | Buy | 8 | 7.85% | 56.43% | N/A | N/A | ||||
| PBYI | PUMA BIOTECHNOLOGY INC | $231.06M | $4.79 | $7.00 | 46.14% | Buy | 1 | 2.20% | 67.87% | N/A | N/A | ||||
| BNTX | BIONTECH SE | $21.89B | $92.06 | $113.57 | 23.37% | Hold | 7 | 0.56% | 175.42% | N/A | N/A | ||||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $7.13B | $113.12 | $190.55 | 68.45% | Strong Buy | 11 | 6.61% | 77.12% | N/A | N/A | ||||
| MDXG | MIMEDX GROUP INC | $1.07B | $7.24 | $12.33 | 70.35% | Strong Buy | 3 | 14.09% | 14.96% | N/A | N/A | ||||
| UTHR | UNITED THERAPEUTICS CORP | $11.80B | $266.05 | $317.17 | 19.21% | Buy | 6 | 7.17% | 6.59% | N/A | N/A | ||||
| NVO | NOVO NORDISK A S | $580.26B | $128.66 | $133.00 | 3.37% | Strong Buy | 6 | 18.85% | 2.84% | N/A | N/A | ||||
| REGN | REGENERON PHARMACEUTICALS INC | $106.66B | $968.00 | $1.03k | 6.70% | Buy | 13 | 7.20% | 5.74% | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.